| Financial Year |
March 31 2020 |
| Monetary Funds |
22,305,309.25 |
| Held-for-trading Financial Assets |
5,100,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
217,730.00 |
| Advances to Suppliers |
9,642,073.08 |
| Other Receivables |
16,883,199.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
203,393,823.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,071,123.89 |
| Total Current Assets |
304,613,259.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
303,691,434.81 |
| Under-construction Projects |
572,815.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
5,536.23 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
54,119,965.29 |
| R&D expenses |
2,560,409.84 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
947,874.63 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
4,059,640.80 |
| Sub-Total of Non-Current Assets |
381,921,123.03 |
| Total Assets |
686,534,382.74 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
7,780,652.75 |
| Accounts Received In Advance |
157,233,510.45 |
| Employee Compensation Payable |
1,053,774.12 |
| Taxes Payable |
670,062.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
62,245,194.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
373,696.88 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
229,356,890.59 |
| Long-term Loans |
190,210,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
190,210,000.00 |
| Total Liabilities |
419,566,890.59 |
| Paid-In Capital(Or Share Stock) |
706,320,000.00 |
| Capital Surplus |
463,681,309.55 |
| Surplus Reserve |
76,791,550.17 |
| LESS:Treasury Stock |
34,093,635.90 |
| Undistributed Profits |
-960,029,612.50 |
| Minority Stockholder's Interest |
14,665,471.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
252,302,020.63 |
| Owner's Equity（Stockholder's Equity） |
266,967,492.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
686,534,382.74 |
